Stockreport

Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares

Zomedica Corp. Common Shares  (ZOM) 
US:NYSE Investor Relations: investors.zomedica.com
PDF ANN ARBOR, Mich., June 10, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic [Read more]